ABSTRACT
Background Higher stress during pregnancy associates with negative outcomes and elevated inflammation. The gut microbiota reflects the environment, lifestyle, and the perinatal period. The gut microbiota, alongside host immune responses, has the potential to aid in identifying when stress is excessive.
Methods Two U.S. cohorts, of 84 pregnant individuals, composed of urban women of color and suburban white women, completed the Perceived Stress Scale-10 (PSS-10) and provided fecal and blood samples at two time points. Confirmatory Factor Analysis assessed the robustness of a two-factor PSS-10 (Emotional Distress and Self-Efficacy) in the two cohorts. Gut microbiota composition was measured by 16S rRNA amplicon sequencing and the immune system activity was assessed with a panel of 21 T-cell related cytokines and chemokines.
Results Emotional Distress levels were higher in the suburban compared to the urban cohort, but levels of Self-Efficacy were similar. Emotional Distress and Self-Efficacy levels were associated with distinct taxonomical signatures and the gut microbiota data improved the prediction of Self-Efficacy levels compared with models based on socio-demographic characteristics alone. Integration of self-reported symptoms, microbial and immune information revealed a possible mediation effect of Bacteroides uniformis between the immune system (through CXCL11) and Self-Efficacy.
Conclusions The study identified links between distinct taxonomical and immunological signatures with perceived stress. The data is congruent with a model where gut microbiome and immune factors may modulate neural plasticity resulting in increased Self-Efficacy during pregnancy. The predictive value of these peripheral markers merit further study.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
BPB was funded by the Arnold O. Beckman Postdoctoral Award and K-12 BIRCWH Award (K12HD101373). MK is supported by the NIMH K23 Training Award (K23MH110660), NARSAD Young Investigator Award from the Brain and Behavior Research Foundation and the P&S Fund. TAEM is supported by the NIMH (K99R00MH109667; R01MH122446; RF1MH120843). This work has been partially funded by the NICHD R03HD095056. REDCap application is supported though the Center for Clinical and Translational Science (CCTS) UL1TR002003.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Study protocols were approved by the University of Illinois Chicago, Chicago, IL, US (IRB# 2014-0325, IRB# 2018-0842) and the University of North Carolina, Chapel Hill, NC, US (IRB# 16-0959, IRB# 16-2783) Institutional Review Boards.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
↵$ Contact authors: Mary Kimmel, mary_kimmel{at}med.unc.edu; Beatriz Peñalver Bernabé, penalver{at}uic.edu, Mary Kimmel, M.D., Assistant Professor, Co-Director of the UNC Perinatal Psychiatry Program, University of North Carolina Chapel Hill School of Medicine, Campus Box #7160, Chapel Hill NC 27599-7160, Beatriz Peñalver Bernabé, Ph.D., Assistant Professor, Department of Biomedical Engineering, College of Medicine, University of Illinois at Chicago, 820 S Wood Street, Chicago IL 60612-4325
Data Availability
Raw data have been deposited in SRA BioProject PRJNA667109. The samples employed for this study within this project are in the Table S3
